181 related articles for article (PubMed ID: 37679570)
1. Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses.
Tremain AC; Wallace RP; Lorentz KM; Thornley TB; Antane JT; Raczy MR; Reda JW; Alpar AT; Slezak AJ; Watkins EA; Maulloo CD; Budina E; Solanki A; Nguyen M; Bischoff DJ; Harrington JL; Mishra R; Conley GP; Marlin R; Dereuddre-Bosquet N; Gallouët AS; LeGrand R; Wilson DS; Kontos S; Hubbell JA
Nat Biomed Eng; 2023 Sep; 7(9):1142-1155. PubMed ID: 37679570
[TBL] [Abstract][Full Text] [Related]
2. Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes.
Wilson DS; Damo M; Hirosue S; Raczy MM; Brünggel K; Diaceri G; Quaglia-Thermes X; Hubbell JA
Nat Biomed Eng; 2019 Oct; 3(10):817-829. PubMed ID: 31358881
[TBL] [Abstract][Full Text] [Related]
3. Induction of antigen-specific tolerance by nanobody-antigen adducts that target class-II major histocompatibility complexes.
Pishesha N; Harmand T; Smeding LY; Ma W; Ludwig LS; Janssen R; Islam A; Xie YJ; Fang T; McCaul N; Pinney W; Sugito HR; Rossotti MA; Gonzalez-Sapienza G; Ploegh HL
Nat Biomed Eng; 2021 Nov; 5(11):1389-1401. PubMed ID: 34127819
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ/Interleukin-27 Axis Induces Programmed Death Ligand 1 Expression in Monocyte-Derived Dendritic Cells and Restores Immune Tolerance in Central Nervous System Autoimmunity.
Casella G; Rasouli J; Thome R; Descamps HC; Vattikonda A; Ishikawa L; Boehm A; Hwang D; Zhang W; Xiao D; Park J; Zhang GX; Alvarez JI; Rostami A; Ciric B
Front Immunol; 2020; 11():576752. PubMed ID: 33193372
[TBL] [Abstract][Full Text] [Related]
5. Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitis.
Hartwell BL; Pickens CJ; Leon M; Northrup L; Christopher MA; Griffin JD; Martinez-Becerra F; Berkland C
J Autoimmun; 2018 Sep; 93():76-88. PubMed ID: 30007842
[TBL] [Abstract][Full Text] [Related]
6. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
Marciani DJ
Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
[TBL] [Abstract][Full Text] [Related]
7. Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis.
LaMothe RA; Kolte PN; Vo T; Ferrari JD; Gelsinger TC; Wong J; Chan VT; Ahmed S; Srinivasan A; Deitemeyer P; Maldonado RA; Kishimoto TK
Front Immunol; 2018; 9():281. PubMed ID: 29552007
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
Derdelinckx J; Mansilla MJ; De Laere M; Lee WP; Navarro-Barriuso J; Wens I; Nkansah I; Daans J; De Reu H; Jolanta Keliris A; Van Audekerke J; Vanreusel V; Pieters Z; Van der Linden A; Verhoye M; Molenberghs G; Hens N; Goossens H; Willekens B; Cras P; Ponsaerts P; Berneman ZN; Martínez-Cáceres EM; Cools N
J Neuroinflammation; 2019 Aug; 16(1):167. PubMed ID: 31416452
[TBL] [Abstract][Full Text] [Related]
9. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance.
Maldonado RA; LaMothe RA; Ferrari JD; Zhang AH; Rossi RJ; Kolte PN; Griset AP; O'Neil C; Altreuter DH; Browning E; Johnston L; Farokhzad OC; Langer R; Scott DW; von Andrian UH; Kishimoto TK
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):E156-65. PubMed ID: 25548186
[TBL] [Abstract][Full Text] [Related]
10. Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance.
Maulloo CD; Cao S; Watkins EA; Raczy MM; Solanki AS; Nguyen M; Reda JW; Shim HN; Wilson DS; Swartz MA; Hubbell JA
Front Immunol; 2021; 12():714842. PubMed ID: 34630389
[TBL] [Abstract][Full Text] [Related]
11. The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies.
Collin M; Ehlers M
Exp Dermatol; 2013 Aug; 22(8):511-4. PubMed ID: 23808883
[TBL] [Abstract][Full Text] [Related]
12. Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis.
von Kutzleben S; Pryce G; Giovannoni G; Baker D
Immunology; 2017 Apr; 150(4):444-455. PubMed ID: 27925187
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Injection of Myelin Oligodendrocyte Glycoprotein-coated PLGA Microparticles Have Tolerogenic Effects in Experimental Autoimmune Encephalomyelitis.
Gholamzad M; Ebtekar M; Shafiee Ardestani M
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):271-281. PubMed ID: 28732440
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.
Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Pozo D; Ganea D; Delgado M
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13562-7. PubMed ID: 16150720
[TBL] [Abstract][Full Text] [Related]
15. Screening Immunomodulators To Skew the Antigen-Specific Autoimmune Response.
Northrup L; Sullivan BP; Hartwell BL; Garza A; Berkland C
Mol Pharm; 2017 Jan; 14(1):66-80. PubMed ID: 28043135
[TBL] [Abstract][Full Text] [Related]
16. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
17. Tolerogenic vaccines for Multiple sclerosis.
Mannie MD; Curtis AD
Hum Vaccin Immunother; 2013 May; 9(5):1032-8. PubMed ID: 23357858
[TBL] [Abstract][Full Text] [Related]
18. Modular immune-homeostatic microparticles promote immune tolerance in mouse autoimmune models.
Chen X; Yang X; Yuan P; Jin R; Bao L; Qiu X; Liu S; Liu T; Gooding JJ; Chen W; Liu G; Bai Y; Liu S; Jin Y
Sci Transl Med; 2021 Mar; 13(584):. PubMed ID: 33692135
[TBL] [Abstract][Full Text] [Related]
19. Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Kleist C; Mohr E; Gaikwad S; Dittmar L; Kuerten S; Platten M; Mier W; Schmitt M; Opelz G; Terness P
J Transl Med; 2016 May; 14(1):99. PubMed ID: 27131971
[TBL] [Abstract][Full Text] [Related]
20. Local delivery of cytokines by retrovirally transduced antigen-specific TCR+ hybridoma cells in experimental autoimmune encephalomyelitis.
Dal Canto RA; Costa G; Shaw MD; Seroogy C; Nolan GP; Fathman CG
Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):83-91. PubMed ID: 9831193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
